Markets / IPO / Bio Medica Laboratories

Bio Medica Laboratories IPO

Updated 18:57

SME IPO on NSE Emerge · Pharmaceuticals

Status

Listed

Price band

₹132–139

Lot size

1000 shares · ₹1,39,000

Subscribed

–

How it listed

Issue price

₹139

Listing price (open)

₹111.20 -20.00%

First-day close

₹115.80 -16.69%

Price now

₹145.35 +4.57%

Listing day	29 May 2026
Open / high / low / close	₹111.20 / ₹116.75 / ₹105.65 / ₹115.80
Shares traded on NSE	21,89,000
Market value at the listing-day close	₹106 cr

Closing prices since listing: 23 Oct ₹149.75, 26 Oct ₹146.40, 27 Oct ₹154.90, 29 Oct ₹146.10, 30 Oct ₹149.95, 2 Nov ₹144.20, 3 Nov ₹144.85, 4 Nov ₹147.00, 5 Nov ₹151.95, 6 Nov ₹145.35.

Bio Medica Laboratories share price, live chart and technicals →

Key dates

Bidding opens	21 May 2026
Bidding closes	25 May 2026
Allotment	26 May 2026
Refunds and shares in demat	27 May 2026
Listing	29 May 2026

Lot size by investor type

Application	Lots	Shares	Amount
Individual investor (minimum)	2	2,000	₹2,78,000
HNI (minimum)	3	3,000	₹4,17,000

At ₹139 a share. In SME IPOs individuals must bid for at least 2 lots.

Subscription

Investor category	Shares bid for
Institutions (QIB)	5,74,000
HNI / NII	24,75,000
HNI, above ₹10 lakh	11,93,000
HNI, ₹2–10 lakh	12,82,000
Retail	52,28,000
Total	82,77,000

NSE does not publish the shares offered to each category for this issue, so times subscribed cannot be shown. NSE and BSE bids together.

Applications from individual investors

2,614 applications in the individual investors' category (bidding for the minimum 2 lots).

NSE does not publish the shares set aside for this category for SME issues, so the chance of allotment cannot be worked out exactly. Winners are picked by lottery.

Demand at each price

Top price ₹139	82.14 lakh shares	99.2%
Lower prices ₹132–138	0.63 lakh shares	0.8%

Shares bid on NSE and BSE at each price in the band. Most bids at the top price, and little at lower prices, means buyers were keen.

Financials and valuation

	At issue price	Now
Market value	₹128 cr	₹133 cr
P/E (last 12 months' profit)	–	–

Revenue, last 12 months	–
Profit, last 12 months	–
Return on equity	–
Debt to equity	–

From results the company filed with NSE (latest period to 31 Mar 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Pharmaceuticals

Company	Listed	Subscribed	On listing	Since IPO
Symbiotec Pharmalab	1 Sept	71.26×	0.00%	+53.20%
Sai Parenteral's	2 Apr	1.05×	+2.04%	+18.97%
KRM Ayurveda SME	29 Jan	–	+27.48%	+68.89%
Corona Remedies	15 Dec	137.04×	+38.42%	+129.86%
Curis Lifesciences SME	14 Nov	–	+14.14%	+38.36%
Rubicon Research	16 Oct	103.90×	+27.84%	+242.12%
Amanta Healthcare	9 Sept	82.61×	+7.14%	+54.98%
Anlon Healthcare	3 Sept	7.13×	-89.89%	-70.33%

IPO details

Price band	₹132–139
Final issue price	₹139
Lot size	1000 shares
Minimum investment	₹2,78,000 (2 lots, the minimum for individuals)
Market	NSE Emerge (SME)
Issue type	100 % Book Building
Face value	₹10
Industry	Pharmaceuticals
Issue size	Initial Public Issue of up to 37,72,000 equity shares comprising a Fresh Issue of 33,95,000 equity shares and an Offer for Sale of 3,77,000 equity shares (Including 1,89,000 Equity shares to be subscribed by Market Maker)
ISIN	INE1BKA01015
Registrar	Skyline Financial Services Private Limited Helpline: 40450193, ipo@skylinerta.com
Lead managers	Narnolia Financial Services Limited
Prospectus	Red herring prospectus (NSE)

Check allotment status

Allotment was finalised on 26 May 2026. Check it on the registrar's page (Skyline Financial Services Private Limited), NSE or BSE with your PAN or application number.

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Bio Medica Laboratories IPO price band and lot size?

The price band is ₹132–139 per share, and one lot is 1000 shares (₹1,39,000 at the upper price).

When is the Bio Medica Laboratories IPO allotment date?

Allotment was finalised on 26 May 2026, the next working day after bidding closed on 25 May 2026.

How many times was the Bio Medica Laboratories IPO subscribed?

Subscription figures are not available yet.

What is the Bio Medica Laboratories IPO listing date?

It listed on 29 May 2026 on NSE Emerge (SME).

What was the Bio Medica Laboratories listing gain?

It opened at ₹111.20 against an issue price of ₹139, a loss of 20.00%. It is now up 4.57% from the issue price.